Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Q2 2023 Earnings Call Transcript

Page 7 of 7

Yale Jen: So, therefore, just adding the patient versus the healthy volunteers?

Pad Chivukula: That’s right.

Yale Jen: Okay, great. Thanks a lot. Again congrats.

Joseph Payne: Yes. Thank you, Yale.

Operator: That was all the time we have for today. I would like to turn the floor back over to Joe for closing comments.

Joseph Payne: Okay. Thanks for participating on the call today, everyone. If there’s remaining questions, please reach out to the team and we’ll get back to you right away. Good night.

Operator: This concludes today’s teleconference. You may disconnect your lines at this time. Thank you for your participation and have a great day.

Follow Arcturus Therapeutics Ltd. (NASDAQ:ARCT)

Page 7 of 7